Buscar
Mostrando ítems 41-50 de 109
Pluripotent Reprogramming of Fibroblasts by Lentiviralmediated Insertion of SOX2, C-MYC, and TCL-1A
(MARY ANN LIEBERT INC, 2011)
Reprogramming of somatic cells to pluripotency promises to boost cellular therapy. Most instances of direct reprogramming have been achieved by forced expression of defined exogenous factors using multiple viral vectors. ...
Hyaluronan oligomers sensitize chronic myeloid leukemia cell lines to the effect of imatinib
(Oxford University Press, 2016-04)
Chronic myeloid leukemia is a myeloproliferative syndrome characterized by the presence of the Philadelphia chromosome (Ph), generated by a reciprocal translocation occurring between chromosomes 9 and 22 [t(9;22)(q34;q11)]. ...
Nuevas armas inmunológicas para la medicina del siglo XXI: Terapia biológica basada en el uso de anticuerpos monoclonales de última generación
(Sociedad Médica de Santiago, 2003)
The fusion of a murine B cell and a myeloma cell generates a hybridoma that
produces monoclonal antibody (mAb). These murine mAb induce the HAMA (human anti-mouse
antibodies) response. Murine mAb have been modified by ...
Ibrutinib impairs the phagocytosis of rituximab-coated leukemic cells from chronic lymphocytic leukemia patients by human macrophages
(Ferrata Storti Foundation, 2015-01)
We have read with great interest the recent article of Kohrt, H.E. et al1 showing that Ibrutinib prevented NK cell mediated cytotoxicity of antibody-coated CLL cells in vitro. They also found that the concurrent treatment ...
Chemotherapeutic potential of the volatile oils from Zanthoxylum rhoifolium Lam leaves
(Elsevier Science BvAmsterdamHolanda, 2007)